• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number C139
Device Problems Air Leak (1008); Device Displays Incorrect Message (2591)
Patient Problem Fainting (1847)
Event Date 12/03/2014
Event Type  Injury  
Event Description
Customer reported alarm #54: anticoagulant line air detected at whole blood processed volume (wbpv) 533ml.Treatment was planned with wbpv target of 1300ml.Treatment was performed in single needle mode with blood prime.Alarm #52: collect line air detected occurred after alarm #54.Customer observed air bubbles in the ac and collect line.Customer decided to end the treatment at wbpv 740ml because of returning alarm #54 and alarm #52.Patient platelet count 80000.Anticoagulant: heparin 10000 iu in 500ml saline, ratio 10:1 access: hickman catheter.Blood prime with rbc after treatment ended, patient collapsed and stopped breathing.Patient was stable after medical intervention.Patient was provided with one rbc transfusion.Bp after medical intervention 113/54 mmhg customer will send smart card for investigation.No service order was generated.
 
Manufacturer Narrative
Batch record review of lot c139 was performed.There were no nonconformances associated with this lot.This lot met release requirements.A review of lot c139 shows no trends.Trends were reviewed for complaint categories, alarm #54: anticoagulent line air detected, alarm #52: collect line air detected, and fainting.No trends were detected.There were no capas initiated.The patient was stable after medical intervention and transfusion.This case is serious and related to therapy.This assessment is based on information available at the time of this report.The smart card was returned for evaluation.A supplemental report will be filed when this analysis is complete.Kit unique identifier (udi) #: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave.
buffalo NY 14211
Manufacturer Contact
440 us route 22 east, ste 140
bridgewater, NJ 08807
MDR Report Key4360452
MDR Text Key5113400
Report Number2523595-2014-00331
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 12/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2016
Device Lot NumberC139
Other Device ID Number10705030100009
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/03/2014
Initial Date FDA Received12/19/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age2 YR
Patient Weight10
-
-